nirmatrelvir, ritonavir

DRUG2 trials

Sponsors

Pfizer

Conditions

COVID-19Covid-19

Unknown Phase

A Study of COVID-19 Patients Receiving Treatment With Nirmatrelvir; Ritonavir in the Kingdom of Saudi Arabia

CompletedNCT06016556

Start: 2023-10-17End: 2024-04-09Updated: 2025-06-05

A Study to Learn About the Use of Paxlovid in Patients With COVID-19 in the Kingdom of Bahrain.

CompletedNCT06291831

Start: 2024-03-13End: 2024-05-14Updated: 2025-08-19

Related Papers

Patient Characteristics and Healthcare Resource Use among Patients With COVID-19 Receiving Treatment with Nirmatrelvir/Ritonavir (PAXLOVID™) in the Kingdom of Saudi Arabia.

2026-05-19

A Retrospective Observational Study on COVID-19 Patients Receiving Treatment with Nirmatrelvir/Ritonavir (PAXLOVID).

2025-10-06